Uncovering unpublished competitor pricing is challenging, but not impossible. This guide offers a practical, step-by-step approach to collect, validate, and benchmark unpublished pricing using secondary research, customer and competitor interviews, and ethical mystery shopping. Learn how to turn fragmented data into actionable pricing intelligence that sharpens your strategy and improves win rates.
Unlock the power of your customers’ voices to shape winning strategies. Learn how to systematically capture and analyze customer feedback, from surveys and interviews to social channels, and transform those insights into informed decisions. Discover ways to align product development, marketing, sales, and competitive positioning with real-world needs, so your organization isn’t guessing what matters, it’s responding with confidence.
What if you could anticipate competitor moves, market shifts and changing customer preferences, not react to them? Discover how integrating primary research into your Early Warning System empowers predictive intelligence, transforming reactive monitoring into proactive strategy.
In a high-stakes, fast-moving pharma landscape, the best competitive intelligence partners do more than deliver data, they drive strategy. This post outlines eight essential traits that set leading CI firms apart, based on real-world buyer insights and evolving industry demands.
At the Pharma CI Conference (Sept 25–26, 2024), leaders discussed how shifts like the IRA’s impact on drug pricing, AI in R&D, and shifting regulatory regimes are reshaping life sciences CI. Read this summary to grasp the conference’s breakout trends and strategic implications.
Through analysis of IO clinical trials (2018–2022), we reveal how top‑20 pharma concentrate on mAb trials globally, while smaller firms explore innovative modalities like BsAb and CAR‑T, and how China is emerging as an IO hub. These patterns offer strategic cues for reshaping your trial portfolio and R&D focus.
This first article, part of a three-post series, focusses on need for such a meeting and underlines the impact of accelerated approvals in the field of Oncology.
Increasingly, employees at all levels of the organization are being called upon to support the competitive intelligence function. Will you be ready? Will you know what to say? What to ask? Read more to learn how to increase effectiveness by simply asking the right questions.
The COVID-19 pandemic has had a very strong impact on all global economies across multiple sectors. Its impact on the US Pharma industry was significant in the first quarter, causing most companies to adjust and realign their businesses in response to the outbreak. The pandemic not only had a direct impact on Q1 revenues, but also affected overall drug development …
Before COVID-19 transpired executives were concerned with their strategic assumptions and the results of getting them wrong. A February 2020 Gartner study cited lack of confidence in strategic assumptions as the leading corporate risk among senior executives across a diverse set of industries and global geographies in Q4 2019. A strategic assumption can be defined as the unstated belief that something is likely to occur to enable an achievable strategic goal. Depending on the …
